Giant Cell Arteritis - 13 Studies Found
| Not yet recruiting |
: Efficacy and Safety Study of Sirukumab in Subjects With Polymyalgia Rheumatica : Polymyalgia Rheumatica : 2016-09-08 :
|
| RECRUITING |
: Efficacy of Tocilizumab in Association to Steroids in Giant Cell Arteritis With Cerebro-vascular Involvement : Giant Cell Arteritis : 2024-11-21 : Tocilizumab will be administered subcutaneously at a dose of 162mg/0.9mLweekly (each week, on the same day) from week 0 to week 24. |
| COMPLETED |
: Ustekinumab for the Treatment of Relapse of Refractory Giant Cell Arteritis : Patients Relapsing Refractory Giant Cell Arteritis : 2024-11-21 : tapering prednisone regimen |